0001203311-17-000074.txt : 20170908
0001203311-17-000074.hdr.sgml : 20170908
20170908193253
ACCESSION NUMBER: 0001203311-17-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170906
FILED AS OF DATE: 20170908
DATE AS OF CHANGE: 20170908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cline Darren S
CENTRAL INDEX KEY: 0001633639
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 171077644
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-09-06
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001633639
Cline Darren S
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
EVP, Commercial
Common Stock
2017-09-06
4
M
0
5024
16.41
A
77230
D
Common Stock
2017-09-06
4
M
0
5024
15.46
A
82254
D
Common Stock
2017-09-06
4
S
0
5024
51.944
D
77230
D
Incentive Stock Option (right to buy)
16.41
2017-09-06
4
M
0
5024
0.0
D
2020-10-29
Common Stock
5024
0
D
Non-Qualified Stock Option (right to buy)
15.46
2017-09-06
4
M
0
5024
0.0
D
2021-08-24
Common Stock
5024
2268
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Shares vested at a rate of 25% on October 29, 2011 and monthly thereafter until all the shares are fully vested on October 29, 2014.
Shares vested at a rate of 25% on August 24, 2012 and monthly thereafter until all the shares are fully vested on August 24, 2015.
/s/ Jean Liu
2017-09-08